Overview
Alexion, AstraZeneca Rare Disease is AstraZeneca's rare disease group, headquartered in Boston, Massachusetts. It focuses on five disease areas: Rare Haematology, Nephrology & Transplant; Rare Neurology; Rare Bone & Endocrine Disorders; Rare Cardiology & Amyloidosis; and Rare Tumours. AstraZeneca completed its acquisition of Alexion Pharmaceuticals on 21 July 2021. Its US sales teams are organised by franchise and differ by disease and call point.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Alexion, AstraZeneca Rare Disease’s careers page.
- Regional Account Manager, aHUS/HSCT-TMA, Orlando, FLOrlando, Florida3d ago
- Regional Account Manager, Rare Neurology, Northeast, FLJacksonville, Florida5d ago$153k–$229k
- Regional Account Manager - NF1 PN - Philly/NJNewark, New Jersey8d ago$173k–$260k
- Regional Account Manager, AHUS/HSCT-TMA - Boston, MABoston, Massachusetts9d ago$153k–$229k
- Regional Account Manager, US HPP, New Haven, CTNew Haven, Connecticut9d ago$153k–$229k
- Regional Account Manager, US HPP, Indianapolis, INNew Haven, Connecticut9d ago$153k–$229k
Divisions
Division information is pending company verification.Once Alexion, AstraZeneca Rare Disease claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Alexion, AstraZeneca Rare Disease
These sections fill in when Alexion, AstraZeneca Rare Disease claims and verifies its page.